about
Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticlesA novel nanoparticle formulation for sustained paclitaxel delivery.Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomes.Enhanced bioavailability of nerve growth factor with phytantriol lipid-based crystalline nanoparticles in cochleaEnhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies.Engineering nanomedicines for improved melanoma therapy: progress and promises.Why Do Membranes of Some Unhealthy Cells Adopt a Cubic Architecture?Recent advances in ocular drug delivery.Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery.Nanostructured liquid-crystalline particles for drug delivery.Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.Self-Assembled Cubic Liquid Crystalline Nanoparticles for Transdermal Delivery of Paeonol.Controlling internal pore sizes in bicontinuous polymeric nanospheresSelf-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part II: optimization of formulation variables using experimental design.Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.Self-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part I: influence of process parameters on their preparation studied by experimental design.Encapsulation of actives for sustained release.Lipidated polymers for the stabilization of cubosomes: nanostructured drug delivery vehicles.Assessment of cubosomal alpha lipoic acid gel efficacy for the aging face: a single-blinded, placebo-controlled, right-left comparative clinical study.In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting.The evolution of bicontinuous polymeric nanospheres in aqueous solution.Novel RAFT amphiphilic brush copolymer steric stabilisers for cubosomes: poly(octadecyl acrylate)-block-poly(polyethylene glycol methyl ether acrylate).
P2860
Q33557899-B37CB5F1-A6B4-4B83-AABC-F33BD0A52FBAQ33573423-4266FD7E-782B-4953-B4D0-FD54398139E4Q33573499-4EA833D8-B8A6-4C7B-8093-22268D3BEB7EQ33644850-23378456-BCAC-4924-9E76-2C5CBF30C92CQ34293494-5FAAC63A-5E20-4DE8-B5C6-FF7F191F7E3EQ34377929-1E15A613-2BB4-42F7-B787-057B42A2C918Q35580829-B2CDEE92-654E-4403-8506-8673D9DB073CQ36265255-CFD2D3E6-D043-4AD3-B80A-2F10FBC3C925Q36620613-62DF006A-2A7A-4795-B0E4-1167FA84A05AQ36936646-998B6513-C55A-4562-801A-9DB1FAA80EF0Q37545528-5A589360-F89F-4853-8BA5-ECF5745C620FQ38059884-D571E254-5010-4DAC-9B71-5643F1B9CCF4Q38100238-B2D17F75-9AC8-4348-8C4B-88592248D28EQ38184591-9E363D51-7A04-4F3B-B3C1-F44E3C7ED9C1Q38227621-A894FFD3-1A5C-4C93-A9A7-536A1D9ACF62Q38948211-F025B78D-31B2-4C7F-8078-C906D76B3FCFQ41606368-1275AEB3-8841-4426-9F9E-BA1C0DD085A7Q41609163-D1F36FAF-2751-4153-B42D-D0B0179B3A6CQ41612480-0A083688-C935-44D7-9BAC-DEAB94367B2BQ41864793-A71ADA7A-EF10-4685-92D5-E8A6F40D7C3CQ44774296-76A31EB0-1C51-488F-8FEA-8E3AF2D84D16Q45270103-0C49E44B-2ACA-41B4-82CA-4F8836E2E306Q47825108-EEBB76FB-4C9C-4E4D-9410-2A8E5CDEEB20Q48206516-B100D1C6-2121-4E9C-95C1-E320A94A84F3Q52092764-41C3A788-7DF4-48DC-84FE-F2EDADDDAF98Q53154633-7C609F6C-1C6B-4734-9CD7-F2EFA22C01D6Q53492918-90D9A26B-402F-4E8F-B37A-2E52D0B45891
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cubosomes: an overview.
@ast
Cubosomes: an overview.
@en
type
label
Cubosomes: an overview.
@ast
Cubosomes: an overview.
@en
prefLabel
Cubosomes: an overview.
@ast
Cubosomes: an overview.
@en
P2093
P356
P1476
Cubosomes: an overview.
@en
P2093
Gopal Garg
Shailendra Saraf
Swarnlata Saraf
P304
P356
10.1248/BPB.30.350
P577
2007-02-01T00:00:00Z